Justice Department Awards More Than $17.5 Million to Support Project Safe Neighborhoods

Washington, DC - The Department of Justice announced Thursday that it has awarded more than $17.5 million in grants to support the Project Safe Neighborhoods (PSN) Program. Funding will support efforts across the country to address violent crime, including the gun violence that is often at its core.

Man Pleads Guilty to Selling Misbranded Vitamin B12 Injectables

Des Moines, Iowa - An Iowa man pleaded guilty Wednesday to a felony charge related to the sale of misbranded vitamin B12 injectable drugs, the Department of Justice announced.

Office on Violence Against Women Announces Awards to 11 Indian Tribal Governments to Exercise Special Domestic Violence Criminal Jurisdiction

Washington, DC - The U.S. Department of Justice Office on Violence Against Women (OVW) Wednesday announced awards to 11 Indian Tribal governments to support them in exercising special domestic violence criminal jurisdiction (SDVCJ). The Violence Against Women Reauthorization Act of 2013 (VAWA 2013) recognized the authority of tribes to exercise SDVCJ over certain defendants, regardless of their Indian or non-Indian status, who commit crimes of domestic violence or dating violence or violate certain protection orders in Indian country.

Woman Convicted of COVID-19 Relief Fraud

Houston, Texas - A federal jury convicted a Texas woman Wednesday for defrauding the Paycheck Protection Program (PPP) of over $1.9 million in loans guaranteed by the Small Business Administration (SBA) under the Coronavirus Aid, Relief, and Economic Security (CARES) Act.

Pharmacist and Two Pharmacies Agree to Pay $1 Million to Resolve Allegations of False Claims for Anti-Overdose Drug

Boston, Massachusetts - Riad “Ray” Zahr, a pharmacist in Dearborn, Michigan, along with two specialty pharmacies that Zahr formerly owned and operated, have agreed to pay the United States $1 million to resolve allegations that they submitted false claims for the drug Evzio. Evzio was an injectable form of naloxone hydrochloride indicated for use to reverse opioid overdose. Evzio was the highest-priced version of naloxone on the market, and insurers frequently required the submission of prior authorization requests before they would approve coverage for Evzio.